Share on StockTwits

Hill-Rom Holdings (NYSE:HRC) issued its quarterly earnings data on Thursday. The company reported $0.45 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.59 by $0.14, Analyst Ratings News reports. The company had revenue of $398.00 million for the quarter, compared to the consensus estimate of $411.41 million.

A number of analysts have recently weighed in on HRC shares. Analysts at Goldman Sachs upgraded shares of Hill-Rom Holdings from a “neutral” rating to a “buy” rating in a research note on Wednesday, June 25th. Analysts at Piper Jaffray raised their price target on shares of Hill-Rom Holdings from $40.00 to $43.00 in a research note on Wednesday, June 25th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $41.97.

Shares of Hill-Rom Holdings (NYSE:HRC) opened at 40.63 on Thursday. Hill-Rom Holdings has a 52-week low of $33.57 and a 52-week high of $44.64. The stock has a 50-day moving average of $40.52 and a 200-day moving average of $38.73. The company has a market cap of $2.325 billion and a price-to-earnings ratio of 34.50.

Hill-Rom Holdings, Inc (NYSE:HRC) is a manufacturer and provider of medical technologies and related services for the health care industry, including patient care systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.